China Cord Blood Corporation ( CO ) was a big mover last session with its shares rising nearly 14% on the day. The upside was owing to the company’s announcement that its board of directors has received a non-binding acquisition proposal letter from Nanjing Xinjiekou Department Store Co., Ltd., wherein the latter has offered to acquire the whole of the company's China business, including all equity interests in its Chinese subsidiaries and assets and resources relating to its business in China. The purchase price offered is around RMB6.0 billion […]